TY - JOUR
T1 - Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
AU - Turcot, Valérie
AU - Lu, Yingchang
AU - Highland, Heather M
AU - Bang, Lia E
AU - Benn, Marianne
AU - Kamstrup, Pia R
AU - Bork-Jensen, Jette
AU - Frikke-Schmidt, Ruth
AU - Gjesing, Anette P
AU - Grarup, Niels
AU - Hansen, Torben
AU - Have, Christian Theil
AU - Jørgensen, Torben
AU - Nielsen, Sune F.
AU - Linneberg, Allan René
AU - Pedersen, Oluf
AU - Pers, Tune H
AU - Vestergaard, Henrik
AU - Nordestgaard, Børge
AU - Tybjærg-Hansen, Anne
AU - Varbo, Anette
AU - CHD Exome+ Consortium
AU - EPIC-CVD Consortium
AU - ExomeBP Consortium
AU - Global Lipids Genetics Consortium
AU - GoT2D Genes Consortium
AU - EPIC-InterAct Consortium
AU - INTERVAL Study
AU - ReproGen Consortium
AU - T2D-Genes Consortium
AU - The MAGIC Investigators
AU - Understanding Society Scientific Group
AU - Lindgren, Cecilia M
AU - Hirschhorn, Joel N
AU - Loos, Ruth J F
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Genome-wide association studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to neuronal biology. Most GWAS loci represent clusters of common, noncoding variants from which pinpointing causal genes remains challenging. Here we combined data from 718,734 individuals to discover rare and low-frequency (minor allele frequency (MAF) < 5%) coding variants associated with BMI. We identified 14 coding variants in 13 genes, of which 8 variants were in genes (ZBTB7B, ACHE, RAPGEF3, RAB21, ZFHX3, ENTPD6, ZFR2 and ZNF169) newly implicated in human obesity, 2 variants were in genes (MC4R and KSR2) previously observed to be mutated in extreme obesity and 2 variants were in GIPR. The effect sizes of rare variants are ~10 times larger than those of common variants, with the largest effect observed in carriers of an MC4R mutation introducing a stop codon (p.Tyr35Ter, MAF = 0.01%), who weighed ~7 kg more than non-carriers. Pathway analyses based on the variants associated with BMI confirm enrichment of neuronal genes and provide new evidence for adipocyte and energy expenditure biology, widening the potential of genetically supported therapeutic targets in obesity.
AB - Genome-wide association studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to neuronal biology. Most GWAS loci represent clusters of common, noncoding variants from which pinpointing causal genes remains challenging. Here we combined data from 718,734 individuals to discover rare and low-frequency (minor allele frequency (MAF) < 5%) coding variants associated with BMI. We identified 14 coding variants in 13 genes, of which 8 variants were in genes (ZBTB7B, ACHE, RAPGEF3, RAB21, ZFHX3, ENTPD6, ZFR2 and ZNF169) newly implicated in human obesity, 2 variants were in genes (MC4R and KSR2) previously observed to be mutated in extreme obesity and 2 variants were in GIPR. The effect sizes of rare variants are ~10 times larger than those of common variants, with the largest effect observed in carriers of an MC4R mutation introducing a stop codon (p.Tyr35Ter, MAF = 0.01%), who weighed ~7 kg more than non-carriers. Pathway analyses based on the variants associated with BMI confirm enrichment of neuronal genes and provide new evidence for adipocyte and energy expenditure biology, widening the potential of genetically supported therapeutic targets in obesity.
KW - Journal Article
UR - https://www.nature.com/articles/s41588-018-0082-3
U2 - 10.1038/s41588-017-0011-x
DO - 10.1038/s41588-017-0011-x
M3 - Journal article
C2 - 29273807
SN - 1061-4036
VL - 50
SP - 26
EP - 41
JO - Nature Genetics
JF - Nature Genetics
ER -